Literature DB >> 32990908

Postoperative diabetes insipidus: how to define and grade this complication?

Friso de Vries1,2, Daniel J Lobatto3,4, Marco J T Verstegen3,4, Wouter R van Furth3,4, Alberto M Pereira5,4, Nienke R Biermasz5,4.   

Abstract

PURPOSE: Although transient diabetes insipidus (DI) is the most common complication of pituitary surgery, there is no consensus on its definition. Polyuria is the most overt symptoms of DI, but can also reflect several physiological adaptive mechanisms in the postoperative phase. These may be difficult to distinguish from and might coincide with DI. The difficulty to distinguish DI from other causes of postoperative polyuria might explain the high variation in incidence rates. This limits interpretation of outcomes, in particular complication rates between centers, and may lead to unnecessary treatment. Aim of this review is to determine a pathophysiologically sound and practical definition of DI for uniform outcome evaluations and treatment recommendations.
METHODS: This study incorporates actual data and the experience of our center and combines this with a review of literature on pathophysiological mechanisms and definitions used in clinical studies reporting of postoperative DI.
RESULTS: The occurrence of excessive thirst and/or hyperosmolality or hypernatremia are the best indicators to discriminate between pathophysiological symptoms and signs of DI and other causes. Urine osmolality distinguishes DI from osmotic diuresis.
CONCLUSIONS: To improve reliability and comparability we propose the following definition for postoperative DI: polyuria (urine production > 300 ml/hour for 3 h) accompanied by a urine specific gravity (USG) < 1.005, and at least one of the following symptoms: excessive thirst, serum osmolality > 300 mosmol/kg, or serum sodium > 145 mmol/L. To prevent unnecessary treatment with desmopressin, we present an algorithm for the diagnosis and treatment of postoperative DI.

Entities:  

Keywords:  Complications; Diabetes insipidus; Fluid imbalance; Pituitary tumor; Transsphenoidal surgery; Vasopressin

Year:  2020        PMID: 32990908      PMCID: PMC7966184          DOI: 10.1007/s11102-020-01083-7

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  42 in total

Review 1.  The experience with transsphenoidal surgery and its importance to outcomes.

Authors:  Jürgen Honegger; Florian Grimm
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 2.  Central diabetes insipidus in children: Diagnosis and management.

Authors:  Giuseppa Patti; Anastasia Ibba; Giovanni Morana; Flavia Napoli; Daniela Fava; Natascia di Iorgi; Mohamad Maghnie
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-06-29       Impact factor: 4.690

3.  Incidence and management of complications of transsphenoidal operation for pituitary adenomas.

Authors:  P M Black; N T Zervas; G L Candia
Journal:  Neurosurgery       Date:  1987-06       Impact factor: 4.654

Review 4.  Adipsic diabetes insipidus in adult patients.

Authors:  Martín Cuesta; Mark J Hannon; Christopher J Thompson
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

5.  Postoperative Diabetes Insipidus and Hyponatremia in Children after Transsphenoidal Surgery for Adrenocorticotropin Hormone and Growth Hormone Secreting Adenomas.

Authors:  Carolina Saldarriaga; Charlampos Lyssikatos; Elena Belyavskaya; Margaret Keil; Prashant Chittiboina; Ninet Sinaii; Constantine A Stratakis; Maya Lodish
Journal:  J Pediatr       Date:  2018-02-01       Impact factor: 4.406

6.  Post-operative diabetes insipidus after endoscopic transsphenoidal surgery.

Authors:  Matthew Schreckinger; Blake Walker; Jordan Knepper; Mark Hornyak; David Hong; Jung-Min Kim; Adam Folbe; Murali Guthikonda; Sandeep Mittal; Nicholas J Szerlip
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

7.  Significance of postoperative fluid diuresis in patients undergoing transsphenoidal surgery for growth hormone-secreting pituitary adenomas.

Authors:  Gabriel Zada; Walavan Sivakumar; Dawn Fishback; Peter A Singer; Martin H Weiss
Journal:  J Neurosurg       Date:  2010-04       Impact factor: 5.115

8.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

9.  Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study.

Authors:  Rudolf A Kristof; Maria Rother; Georg Neuloh; Dietrich Klingmüller
Journal:  J Neurosurg       Date:  2009-09       Impact factor: 5.115

10.  Factors Associated with Postoperative Diabetes Insipidus after Pituitary Surgery.

Authors:  Antonio L Faltado; Anna Angelica Macalalad-Josue; Ralph Jason S Li; John Paul M Quisumbing; Marc Gregory Y Yu; Cecilia A Jimeno
Journal:  Endocrinol Metab (Seoul)       Date:  2017-11-21
View more
  12 in total

Review 1.  Diagnosis and Management of Central Diabetes Insipidus in Adults.

Authors:  Maria Tomkins; Sarah Lawless; Julie Martin-Grace; Mark Sherlock; Chris J Thompson
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

2.  Sevoflurane anesthesia rather than propofol anesthesia is associated with 3-month postoperative hypocortisolism in patients undergoing endoscopic transsphenoidal surgery for non-functional pituitary adenoma with preoperative normal hypothalamic-pituitary-adrenal axis.

Authors:  Seungeun Choi; Yoon Jung Kim; Hyongmin Oh; Nayoung Kim; Yong Hwy Kim; Hee-Pyoung Park
Journal:  Acta Neurochir (Wien)       Date:  2022-05-31       Impact factor: 2.816

3.  Novel Nomograms to Predict Delayed Hyponatremia After Transsphenoidal Surgery for Pituitary Adenoma.

Authors:  Kunzhe Lin; Ran Zeng; Shuwen Mu; Yinghong Lin; Shousen Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

Review 4.  Autoimmunity Related to Adipsic Hypernatremia and ROHHAD Syndrome.

Authors:  Akari Nakamura-Utsunomiya
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

5.  Change in cephalocaudal tumor cavity diameter after transsphenoidal surgery is a predictor of diabetes insipidus in pituitary adenoma.

Authors:  Kunzhe Lin; Kaichun Fan; Shuwen Mu; Shousen Wang
Journal:  Eur J Med Res       Date:  2022-05-25       Impact factor: 4.981

6.  Increased oxytocin release precedes hyponatremia after pituitary surgery.

Authors:  Paul Eugène Constanthin; Nathalie Isidor; Sophie de Seigneux; Shahan Momjian
Journal:  Pituitary       Date:  2021-01-28       Impact factor: 4.107

7.  The role of social networks in diabetes self-care: A cross-sectional study.

Authors:  Khadijeh Moulaei; Zahra Dinari; Fatemeh Dinari; Yunes Jahani; Kambiz Bahaadinbeigy
Journal:  Health Sci Rep       Date:  2022-04-26

8.  Predicting the Need for Desmopressin Treatment During Inpatient and After Discharge Following Endoscopic Sellar Surgery.

Authors:  Chia-En Wong; Wei-Hsin Wang; Ming-Ying Lan; Po-Hsuan Lee; Chi-Chen Huang; Pei-Fang Su; Jung-Shun Lee
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

9.  The Efficacy of Targeted Perioperative Management for Diabetic Patients with Traumatic Calcaneal Fractures.

Authors:  Sibin Hao; Yunpeng Liu; Mingtai Yu; Fang Sun; Dezhang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-28       Impact factor: 2.650

10.  Costs and Its Determinants in Pituitary Tumour Surgery.

Authors:  Alies J Dekkers; Friso de Vries; Amir H Zamanipoor Najafabadi; Emmy M van der Hoeven; Marco J T Verstegen; Alberto M Pereira; Wouter R van Furth; Nienke R Biermasz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.